US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INDIVIOR PLC

34.93

+0.06000.17%

Pre-market: 35.500.5700+1.63%04:07 EDT

Volume:1.96M

Turnover:68.26M

Market Cap:4.12B

PE:12.63

High:35.30

Open:34.87

Low:34.33

Close:34.87

52wk High:42.81

52wk Low:22.22

Shares:118.00M

Float Shares:116.45M

Volume Ratio:1.05

T/O Rate:1.69%

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.77

EPS(LYR):1.64

ROE:12.20%

ROA:26.40%

PB:-19.82

PE(LYR):21.30

Loading ...

Overview Company News Filings

Indivior Pharmaceuticals, Inc : Stifel Raises Target Price to $52 From $42

THOMSON REUTERS

A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Q1 Beat, Raised 2026 Guidance And Buyback News

Simply Wall St.

Sector Update: Health Care

MT Newswires Live

Indivior Pharmaceuticals Enters $175 Million Accelerated Share Repurchase Agreement

MT Newswires Live

Indivior announces $175M accelerated share repurchase program

Indivior Announces $175 Million Accelerated Share Repurchase

THOMSON REUTERS

Indivior Earnings Call Highlights SUBLOCADE-Fueled Momentum

Indivior Pharmaceuticals, Inc reports results for the quarter ended March 31 - Earnings Summary

Indivior Pharmaceuticals Q1 revenue rises 19%, beats estimates

Indivior Pharmaceuticals Q1 Revenue USD 317 Million Vs. IBES Estimate USD 272.8 Million

Indivior Q1 GAAP net income rises 89% to $89 million; revenue climbs 19% to $317 million

Indivior Q1 Adj. EPS $0.96 Beats $0.66 Estimate, Sales $317.000M Beat $272.840M Estimate

Benzinga Earnings

Indivior Pharmaceuticals, Inc - Revises FY 2026 Net Revenue Guidance to $1,215 Mln-$1,285 Mln

THOMSON REUTERS

Indivior Pharmaceuticals, Inc - Revises FY 2026 Adj Ebitda Guidance to $620 Mln-$660 Mln

THOMSON REUTERS

Indivior Pharmaceuticals, Inc - Revises FY 2026 Sublocade Net Revenue Guidance to $950 Mln-$990 Mln

THOMSON REUTERS

Addex Therapeutics publishes 2025 annual report

Addex FY25 net loss widens to CHF 6.7 million; cash falls to CHF 1.6 million

Evaluating Indivior Pharmaceuticals (NasdaqGS:INDV) After New ASAM 2026 Data On Sublocade Effectiveness

Simply Wall St.

Indivior study links Sublocade-based OUD remission to better quality-of-life outcomes

Does Indivior (INDV) Survey Support For Long-Acting Buprenorphine Strengthen Its Criminal Justice Strategy?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/INDV/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INDV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INDV\",,,,,undefined,":{"symbol":"INDV","market":"US","secType":"STK","nameCN":"INDIVIOR PLC","latestPrice":34.93,"timestamp":1788206400000,"preClose":34.87,"halted":0,"volume":1963276,"hourTrading":{"tag":"盘前","latestPrice":35.5,"preClose":34.93,"latestTime":"04:07 EDT","volume":1,"amount":35.5,"timestamp":1788250045013,"change":0.57,"changeRate":0.016318,"amplitude":0},"delay":0,"changeRate":0.0017206767995412181,"floatShares":116454522,"shares":118000000,"eps":2.766067,"marketStatus":"Pre-Mkt","change":0.06,"latestTime":"09-01 06:09:24 EDT","open":34.87,"high":35.3,"low":34.33,"amount":68264043.002652,"amplitude":0.027818,"askPrice":35.24,"askSize":47,"bidPrice":34.51,"bidSize":47,"shortable":3,"etf":0,"ttmEps":2.766067,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788269400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":34.93,"preHourTrading":{"tag":"盘前","latestPrice":35.5,"preClose":34.93,"latestTime":"04:07 EDT","volume":1,"amount":35.5,"timestamp":1788250045013,"change":0.57,"changeRate":0.016318,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":34.93,"preClose":34.93,"latestTime":"19:30 EDT","volume":120563,"amount":4211173.07022,"timestamp":1788219002693,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.0490047718125561,"impliedVol":0.2742,"impliedVolPercentile":0.0438},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INDV\",,,,,undefined,":{"symbol":"INDV","floatShares":116454522,"roa":"26.40%","roe":"12.20%","lyrEps":1.64,"volumeRatio":1.0490047718125561,"shares":118000000,"dividePrice":0,"high":35.3,"amplitude":0.027818,"preClose":34.87,"low":34.33,"week52Low":22.22,"pbRate":"-19.82","psRate":"3.10","week52High":42.81,"institutionHeld":0,"latestPrice":34.93,"eps":2.766067,"divideRate":0,"volume":1963276,"delay":0,"ttmEps":2.766067,"open":34.87,"prevYearClose":35.88,"prevWeekClose":34.87,"prevMonthClose":34.93,"prevQuarterClose":41.03,"fiveDayClose":36.18,"twentyDayClose":37.37,"sixtyDayClose":37.45,"dividendPayoutRate":1.9539525374644688,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.02676056338028169},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INDV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-03","symbol":"INDV","fiscalQuarterEnding":"2026/06","expectedEps":0.97,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785729600000,"reportTimeType":"pre","actualEps":1.15},{"market":"US","date":"2026-04-30","symbol":"INDV","fiscalQuarterEnding":"2026/03","expectedEps":0.64,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"pre","actualEps":0.96},{"market":"US","date":"2026-02-26","symbol":"INDV","fiscalQuarterEnding":"2025/12","expectedEps":0.65,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":0.82},{"market":"US","date":"2026-01-26","symbol":"INDV","reason":null,"defaultRemindTime":1769437800000,"announcedDate":"2026-01-23","type":"delisting","dateTimestamp":1769403600000},{"market":"US","date":"2025-10-30","symbol":"INDV","fiscalQuarterEnding":"2025/09","expectedEps":0.38,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1761796800000,"reportTimeType":"pre","actualEps":0.72}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INDV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INDV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1782014400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INDV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INDV","date":"2026-08-31","current":12.628038,"percent":0.426128,"low":-539.080629,"twenty":-25.020145,"median":18.160958,"eighty":56.560749,"high":1520.868351,"avg":88.13207,"sd":415.152346,"marketCap":4115135940},"quantilePoints":[{"date":"2024-01-05","current":-8.731325,"twenty":-8.731325,"median":-8.731325,"eighty":-8.731325,"marketCap":2051861355.61},{"date":"2024-01-12","current":-9.061129,"twenty":-8.930914,"median":-8.915467,"eighty":-8.872434,"marketCap":2129365213.58},{"date":"2024-01-19","current":-9.036937,"twenty":-9.037083,"median":-8.926675,"eighty":-8.867596,"marketCap":2123680078.16},{"date":"2024-01-26","current":-10.054308,"twenty":-9.927259,"median":-9.036937,"eighty":-8.901284,"marketCap":2362762158.39},{"date":"2024-02-02","current":-10.004449,"twenty":-10.01442,"median":-9.223686,"eighty":-8.919649,"marketCap":2351045521.54},{"date":"2024-02-09","current":-10.098427,"twenty":-10.051065,"median":-9.895497,"eighty":-8.929219,"marketCap":2373130321.56},{"date":"2024-02-16","current":-10.175342,"twenty":-10.179852,"median":-9.943541,"eighty":-8.977536,"marketCap":2391205561.35},{"date":"2024-02-23","current":1442.16344,"twenty":-10.183288,"median":-9.929623,"eighty":-8.965881,"marketCap":2884326878.5},{"date":"2024-03-01","current":1520.868351,"twenty":-10.175772,"median":-9.860171,"eighty":-8.862758,"marketCap":3041736702.67},{"date":"2024-03-08","current":1456.331845,"twenty":-10.129193,"median":-9.478841,"eighty":1456.594636,"marketCap":2912663689.17},{"date":"2024-03-15","current":1406.519641,"twenty":-10.071956,"median":-9.037667,"eighty":1456.594636,"marketCap":2813039280.38},{"date":"2024-03-22","current":1416.408463,"twenty":-10.051876,"median":-8.960053,"eighty":1447.830802,"marketCap":2832816924.48},{"date":"2024-03-28","current":1455.260447,"twenty":-10.040734,"median":-8.915467,"eighty":1455.903286,"marketCap":2910520894.48},{"date":"2024-04-05","current":1458.075233,"twenty":-10.017652,"median":-8.848243,"eighty":1457.639065,"marketCap":2916150468.02},{"date":"2024-04-12","current":1329.065563,"twenty":-9.996443,"median":1356.65224,"eighty":1456.726031,"marketCap":2658131124.79},{"date":"2024-04-19","current":1279.103138,"twenty":-9.969287,"median":1309.349865,"eighty":1455.903286,"marketCap":2558206276.88},{"date":"2024-04-26","current":476.533403,"twenty":-9.944147,"median":1284.511395,"eighty":1452.111517,"marketCap":2382667015.68},{"date":"2024-05-03","current":485.430033,"twenty":-9.931801,"median":1275.015426,"eighty":1446.43078,"marketCap":2427150166.81},{"date":"2024-05-10","current":484.77744,"twenty":-9.909437,"median":493.219646,"eighty":1443.862237,"marketCap":2423887197.01},{"date":"2024-05-17","current":457.733314,"twenty":-9.881367,"median":488.116405,"eighty":1441.351048,"marketCap":2288666574.17},{"date":"2024-05-24","current":465.20437,"twenty":-9.858941,"median":485.295631,"eighty":1439.871356,"marketCap":2326021847.95},{"date":"2024-05-31","current":496.261466,"twenty":-9.799964,"median":486.27573,"eighty":1436.258175,"marketCap":2481307333.36},{"date":"2024-06-07","current":439.995107,"twenty":-9.5344,"median":485.430033,"eighty":1423.367779,"marketCap":2199975534.13},{"date":"2024-06-14","current":451.615042,"twenty":-9.386243,"median":484.77744,"eighty":1423.350602,"marketCap":2258075214.65},{"date":"2024-06-21","current":447.135681,"twenty":-9.126152,"median":483.175553,"eighty":1421.904534,"marketCap":2235678403.11},{"date":"2024-06-28","current":420.240739,"twenty":-9.056437,"median":482.881297,"eighty":1420.903799,"marketCap":2101203699.91},{"date":"2024-07-05","current":399.169394,"twenty":-9.037667,"median":478.317711,"eighty":1418.346927,"marketCap":1995846972.62},{"date":"2024-07-12","current":281.71779,"twenty":-9.036937,"median":474.886858,"eighty":1416.476807,"marketCap":1408588947.59},{"date":"2024-07-15","current":269.124484,"twenty":-9.027388,"median":474.396895,"eighty":1416.463138,"marketCap":1345622420.31},{"date":"2024-08-02","current":-12.681184,"twenty":-9.037375,"median":474.162636,"eighty":1416.449469,"marketCap":1788046959.52},{"date":"2024-08-09","current":-11.831658,"twenty":-9.742833,"median":463.001654,"eighty":1415.475285,"marketCap":1668263747.87},{"date":"2024-08-16","current":-11.531835,"twenty":-9.931801,"median":456.721797,"eighty":1411.053167,"marketCap":1625988694.51},{"date":"2024-08-23","current":-11.359567,"twenty":-10.017652,"median":455.124507,"eighty":1403.016644,"marketCap":1601698904.31},{"date":"2024-08-30","current":-11.517339,"twenty":-10.144576,"median":449.847335,"eighty":1394.819348,"marketCap":1623944812.52},{"date":"2024-09-06","current":-9.739044,"twenty":-10.190159,"median":447.535315,"eighty":1390.076063,"marketCap":1373205236.08},{"date":"2024-09-13","current":-9.093341,"twenty":-10.176202,"median":437.901092,"eighty":1388.200752,"marketCap":1282161095.35},{"date":"2024-09-20","current":-8.695405,"twenty":-10.159959,"median":436.792984,"eighty":1385.619667,"marketCap":1226052087.81},{"date":"2024-09-27","current":-9.187795,"twenty":-10.089603,"median":420.240739,"eighty":1373.204246,"marketCap":1295479177.06},{"date":"2024-10-04","current":-9.452398,"twenty":-10.053497,"median":411.279432,"eighty":1328.888735,"marketCap":1332788098.86},{"date":"2024-10-11","current":-6.894174,"twenty":-10.045494,"median":397.767615,"eighty":1324.41511,"marketCap":972078462.1},{"date":"2024-10-18","current":-7.729502,"twenty":-10.022053,"median":275.421137,"eighty":1306.911197,"marketCap":1089859827.76},{"date":"2024-10-25","current":-387.254131,"twenty":-10.022053,"median":258.931158,"eighty":1295.294828,"marketCap":1161762392.56},{"date":"2024-10-31","current":-376.128091,"twenty":-10.098427,"median":-6.913465,"eighty":1287.84805,"marketCap":1128384273.39},{"date":"2024-11-08","current":-434.650258,"twenty":-10.197534,"median":-7.218189,"eighty":1281.174739,"marketCap":1303950773.11},{"date":"2024-11-15","current":-417.553766,"twenty":-10.357169,"median":-7.68996,"eighty":1279.103138,"marketCap":1252661295.74},{"date":"2024-11-22","current":-455.401138,"twenty":-11.279742,"median":-7.770979,"eighty":1275.015426,"marketCap":1366203413.46},{"date":"2024-11-29","current":-475.483527,"twenty":-11.472459,"median":-8.119915,"eighty":1262.088941,"marketCap":1426450581.27},{"date":"2024-12-06","current":-462.637374,"twenty":-11.520238,"median":-8.577538,"eighty":649.987226,"marketCap":1387912124.34},{"date":"2024-12-13","current":-484.970807,"twenty":-11.624468,"median":-8.706737,"eighty":497.452148,"marketCap":1454912419.5},{"date":"2024-12-20","current":-483.00699,"twenty":-11.880785,"median":-8.81707,"eighty":496.483725,"marketCap":1449020970.4},{"date":"2024-12-27","current":-524.024438,"twenty":-12.457859,"median":-8.855646,"eighty":495.297532,"marketCap":1572073311.64},{"date":"2025-01-03","current":-526.020236,"twenty":-230.749328,"median":-8.892068,"eighty":493.586593,"marketCap":1578060706.99},{"date":"2025-01-10","current":-497.27008,"twenty":-384.916258,"median":-8.907363,"eighty":491.400602,"marketCap":1491810238.16},{"date":"2025-01-17","current":-486.412641,"twenty":-393.098632,"median":-8.915467,"eighty":488.91137,"marketCap":1459237922.85},{"date":"2025-01-24","current":-489.294402,"twenty":-425.635451,"median":-8.960053,"eighty":488.290719,"marketCap":1467883205.21},{"date":"2025-01-31","current":-495.059612,"twenty":-434.650258,"median":-9.004691,"eighty":488.174377,"marketCap":1485178837.55},{"date":"2025-02-07","current":-398.440394,"twenty":-438.198605,"median":-9.035763,"eighty":488.116405,"marketCap":1195321181.39},{"date":"2025-02-14","current":-410.047551,"twenty":-437.752568,"median":-9.061129,"eighty":487.121427,"marketCap":1230142653.13},{"date":"2025-02-21","current":-22.522233,"twenty":-439.344773,"median":-9.095438,"eighty":485.768312,"marketCap":1081067217.57},{"date":"2025-02-28","current":-22.859537,"twenty":-437.841775,"median":-9.294936,"eighty":485.214989,"marketCap":1097257759.94},{"date":"2025-03-07","current":-24.283428,"twenty":-437.023459,"median":-9.444366,"eighty":484.854198,"marketCap":1165604557.36},{"date":"2025-03-14","current":605.149026,"twenty":-435.088443,"median":-9.294936,"eighty":488.127999,"marketCap":1210298050.41},{"date":"2025-03-21","current":-25.271265,"twenty":-433.037368,"median":-9.386243,"eighty":488.197645,"marketCap":1213020698.87},{"date":"2025-03-28","current":-24.738754,"twenty":-430.777799,"median":-9.448382,"eighty":488.127999,"marketCap":1187460219.29},{"date":"2025-04-04","current":-24.352592,"twenty":-427.288281,"median":-9.739044,"eighty":487.320423,"marketCap":1168924445.9},{"date":"2025-04-11","current":-23.146184,"twenty":-425.814745,"median":-9.877834,"eighty":485.768312,"marketCap":1111016863.05},{"date":"2025-04-17","current":-23.722243,"twenty":-421.727469,"median":-9.929623,"eighty":485.26875,"marketCap":1138667669.28},{"date":"2025-04-25","current":-21.827382,"twenty":-418.181119,"median":-9.984433,"eighty":484.930955,"marketCap":1353297690.88},{"date":"2025-05-02","current":-23.745782,"twenty":-414.153201,"median":-10.038354,"eighty":483.882407,"marketCap":1472238458.47},{"date":"2025-05-09","current":-22.159707,"twenty":-410.782993,"median":-10.098427,"eighty":483.219619,"marketCap":1373901817.96},{"date":"2025-05-16","current":-22.569779,"twenty":-408.327019,"median":-10.185005,"eighty":482.998999,"marketCap":1399326293.84},{"date":"2025-05-23","current":-22.3193,"twenty":-401.936236,"median":-10.311545,"eighty":482.806461,"marketCap":1383796581.45},{"date":"2025-05-30","current":-25.63971,"twenty":-396.501678,"median":-10.3517,"eighty":480.981026,"marketCap":1589662006.96},{"date":"2025-06-06","current":-27.767026,"twenty":-393.177531,"median":-11.138759,"eighty":477.603988,"marketCap":1721555638.78},{"date":"2025-06-13","current":-28.024212,"twenty":-392.348167,"median":-11.279742,"eighty":476.07077,"marketCap":1737501138.51},{"date":"2025-06-20","current":-28.284472,"twenty":-391.855975,"median":-11.446173,"eighty":475.180835,"marketCap":1753637267.93},{"date":"2025-06-27","current":-27.245913,"twenty":-390.345823,"median":-11.490318,"eighty":474.303192,"marketCap":1689246563.77},{"date":"2025-07-03","current":-31.054113,"twenty":-387.254131,"median":-11.508717,"eighty":473.928378,"marketCap":1925355009.01},{"date":"2025-07-11","current":-31.171056,"twenty":-387.002934,"median":-11.55631,"eighty":465.20437,"marketCap":1932605447.05},{"date":"2025-07-18","current":-32.333828,"twenty":-385.010735,"median":-11.628362,"eighty":463.001654,"marketCap":2004697356.56},{"date":"2025-07-25","current":-33.722781,"twenty":-384.538351,"median":-11.705533,"eighty":457.733314,"marketCap":2090812381.22},{"date":"2025-08-01","current":47.55378,"twenty":-383.933492,"median":-11.954476,"eighty":457.459813,"marketCap":2520350364},{"date":"2025-08-08","current":51.908953,"twenty":-383.123313,"median":-11.661073,"eighty":455.983781,"marketCap":2751174531},{"date":"2025-08-15","current":54.545599,"twenty":-376.128091,"median":-11.608831,"eighty":455.390371,"marketCap":2890916729},{"date":"2025-08-22","current":56.617249,"twenty":-35.016046,"median":-11.531835,"eighty":455.124507,"marketCap":3000714171},{"date":"2025-08-29","current":56.217043,"twenty":-34.774556,"median":-11.495509,"eighty":452.199783,"marketCap":2979503301},{"date":"2025-09-05","current":58.218069,"twenty":-34.549166,"median":-11.478929,"eighty":451.73199,"marketCap":3085557648},{"date":"2025-09-12","current":56.217043,"twenty":-34.412321,"median":-11.359567,"eighty":448.786711,"marketCap":2979503301},{"date":"2025-09-19","current":53.886437,"twenty":-33.856664,"median":-11.154173,"eighty":447.963884,"marketCap":2855981179},{"date":"2025-09-26","current":53.698106,"twenty":-33.722781,"median":-10.357169,"eighty":447.295534,"marketCap":2845999594},{"date":"2025-10-03","current":54.757472,"twenty":-33.367838,"median":-10.329434,"eighty":441.423222,"marketCap":2902146013},{"date":"2025-10-10","current":56.852663,"twenty":-32.522883,"median":-10.193594,"eighty":438.319895,"marketCap":3013191153},{"date":"2025-10-17","current":58.123903,"twenty":-32.191426,"median":-10.136885,"eighty":437.230259,"marketCap":3080566855},{"date":"2025-10-24","current":59.51285,"twenty":-31.936305,"median":-10.050254,"eighty":437.029825,"marketCap":3154181049},{"date":"2025-10-31","current":49.115471,"twenty":-31.768326,"median":-9.994441,"eighty":436.655789,"marketCap":3634544856},{"date":"2025-11-07","current":53.771536,"twenty":-31.614854,"median":-9.940515,"eighty":432.826301,"marketCap":3979093697},{"date":"2025-11-14","current":50.329618,"twenty":-31.467797,"median":-9.877834,"eighty":422.57095,"marketCap":3724391747},{"date":"2025-11-21","current":53.602815,"twenty":-31.224616,"median":-9.739044,"eighty":418.358561,"marketCap":3966608307},{"date":"2025-11-28","current":33.831379,"twenty":-31.10089,"median":-9.452398,"eighty":417.079998,"marketCap":4195090939},{"date":"2025-12-05","current":34.838265,"twenty":-31.035365,"median":-9.406482,"eighty":410.227055,"marketCap":4319944836},{"date":"2025-12-12","current":36.036459,"twenty":-30.949051,"median":-9.187795,"eighty":401.908655,"marketCap":4468520973},{"date":"2025-12-19","current":35.784738,"twenty":-30.882422,"median":-9.077235,"eighty":398.328327,"marketCap":4437307499},{"date":"2025-12-26","current":36.409007,"twenty":-30.838389,"median":-9.037302,"eighty":355.290696,"marketCap":4514716915},{"date":"2026-01-02","current":36.127079,"twenty":-30.768476,"median":-9.020236,"eighty":289.603812,"marketCap":4479757824},{"date":"2026-01-09","current":35.754531,"twenty":-30.593054,"median":-8.994538,"eighty":279.199129,"marketCap":4433561882},{"date":"2026-01-16","current":33.111455,"twenty":-30.162922,"median":-8.926675,"eighty":268.955119,"marketCap":4105820402},{"date":"2026-01-23","current":33.770965,"twenty":-29.887031,"median":-8.908086,"eighty":268.277658,"marketCap":4187599705},{"date":"2026-01-30","current":34.949022,"twenty":-29.648103,"median":-8.907363,"eighty":262.669758,"marketCap":4333678764},{"date":"2026-02-06","current":34.687232,"twenty":-28.870039,"median":-8.882251,"eighty":139.280173,"marketCap":4301216751},{"date":"2026-02-13","current":33.99248,"twenty":-28.353691,"median":-8.848243,"eighty":59.385726,"marketCap":4215067562},{"date":"2026-02-20","current":34.677163,"twenty":-28.238411,"median":-8.731325,"eighty":59.244477,"marketCap":4299968212},{"date":"2026-02-27","current":20.042023,"twenty":-28.144728,"median":-8.655829,"eighty":59.018479,"marketCap":4208824867},{"date":"2026-03-06","current":19.087338,"twenty":-28.07439,"median":-8.478095,"eighty":58.74069,"marketCap":4008341006},{"date":"2026-03-13","current":18.378635,"twenty":-27.9958,"median":-7.827701,"eighty":58.632399,"marketCap":3859513368},{"date":"2026-03-20","current":18.164238,"twenty":-27.926913,"median":-7.703119,"eighty":58.505275,"marketCap":3814489881},{"date":"2026-03-27","current":17.836686,"twenty":-27.874039,"median":-7.514349,"eighty":58.29811,"marketCap":3745703997},{"date":"2026-04-02","current":17.794815,"twenty":-27.836472,"median":-6.995266,"eighty":58.236902,"marketCap":3736911077},{"date":"2026-04-10","current":18.758579,"twenty":-27.751968,"median":-6.894174,"eighty":58.199236,"marketCap":3939301693},{"date":"2026-04-17","current":18.294115,"twenty":-27.679313,"median":16.982644,"eighty":58.114486,"marketCap":3841764047},{"date":"2026-04-24","current":19.252074,"twenty":-27.620734,"median":17.503178,"eighty":58.072112,"marketCap":4042935443},{"date":"2026-05-01","current":17.794815,"twenty":-27.559726,"median":17.69031,"eighty":58.025029,"marketCap":4484293293},{"date":"2026-05-08","current":19.159181,"twenty":-27.4491,"median":17.730951,"eighty":57.88378,"marketCap":4828113496},{"date":"2026-05-15","current":18.302823,"twenty":-27.391357,"median":17.815751,"eighty":57.742531,"marketCap":4612311454},{"date":"2026-05-22","current":18.123811,"twenty":-27.288803,"median":17.836686,"eighty":57.620115,"marketCap":4567200292},{"date":"2026-05-29","current":17.712566,"twenty":-27.245913,"median":17.896416,"eighty":57.582449,"marketCap":4463566543},{"date":"2026-06-05","current":18.118973,"twenty":-27.042075,"median":17.815751,"eighty":57.417659,"marketCap":4565981072},{"date":"2026-06-12","current":18.447969,"twenty":-26.689807,"median":17.954474,"eighty":57.347034,"marketCap":4648888071},{"date":"2026-06-18","current":18.351205,"twenty":-26.089973,"median":18.089943,"eighty":57.271701,"marketCap":4624503659},{"date":"2026-06-26","current":19.976832,"twenty":-25.921332,"median":18.140745,"eighty":57.196369,"marketCap":5034161774},{"date":"2026-07-02","current":19.473662,"twenty":-25.822694,"median":18.173171,"eighty":57.168119,"marketCap":4907362834},{"date":"2026-07-10","current":19.981671,"twenty":-25.687845,"median":18.198802,"eighty":56.975079,"marketCap":5035380995},{"date":"2026-07-17","current":19.63816,"twenty":-25.580272,"median":18.293631,"eighty":56.852663,"marketCap":4948816334},{"date":"2026-07-24","current":19.599455,"twenty":-25.493702,"median":18.346367,"eighty":56.796163,"marketCap":4939062569},{"date":"2026-07-31","current":19.459148,"twenty":-25.451449,"median":18.378635,"eighty":56.749081,"marketCap":4903705172},{"date":"2026-08-07","current":12.819067,"twenty":-25.369514,"median":18.324595,"eighty":56.725539,"marketCap":4563587806},{"date":"2026-08-14","current":12.669892,"twenty":-25.215019,"median":18.293147,"eighty":56.692581,"marketCap":4510481664},{"date":"2026-08-21","current":12.524033,"twenty":-25.098157,"median":18.192754,"eighty":56.645498,"marketCap":4458555659},{"date":"2026-08-28","current":11.701915,"twenty":-25.029903,"median":18.164238,"eighty":56.579583,"marketCap":4165881809},{"date":"2026-08-31","current":11.559371,"twenty":-25.020145,"median":18.160958,"eighty":56.560749,"marketCap":4115135940}],"updateTime":1788257364670},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INDV\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633901252","title":"Indivior Pharmaceuticals, Inc : Stifel Raises Target Price to $52 From $42","url":"https://stock-news.laohu8.com/highlight/detail?id=2633901252","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633901252?lang=en_us&edition=fundamental","pubTime":"2026-05-06 15:16","pubTimestamp":1778051794,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nFWN41J0DL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633911857","title":"A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Q1 Beat, Raised 2026 Guidance And Buyback News","url":"https://stock-news.laohu8.com/highlight/detail?id=2633911857","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633911857?lang=en_us&edition=fundamental","pubTime":"2026-05-05 18:23","pubTimestamp":1777976589,"startTime":"0","endTime":"0","summary":"Indivior Pharmaceuticals (INDV) is back on investors' radars after a busy stretch that combined strong Q1 2026 results, a raised full year revenue outlook, and a fresh accelerated share repurchase plan.\nSee our latest analysis for Indivior Pharmaceuticals.\nThe recent Q1 beat, raised 2026 guidance, and the new accelerated share repurchase agreement have all coincided with strong momentum, with a 27.93% 1 month share price return and a very large 1 year total shareholder return that far...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior-pharmaceuticals/news/a-look-at-indivior-pharmaceuticals-nasdaqgsindv-valuation-af-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior-pharmaceuticals/news/a-look-at-indivior-pharmaceuticals-nasdaqgsindv-valuation-af-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632955396","title":"Sector Update: Health Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2632955396","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632955396?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:58","pubTimestamp":1777899531,"startTime":"0","endTime":"0","summary":"Health care stocks were flat to lower premarket Monday, with the iShares Biotechnology ETF  inactive and the State Street Health Care Select Sector SPDR ETF  down 0.5%.Indivior Pharmaceuticals  shares were up more than 3% after the company said it has entered into a $175 million accelerated share repurchase agreement with Barclays Bank, to be executed under the company's existing $400 million buyback program.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4007","BK4585","XLV","LABU","IBB","XBI","INDV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632930082","title":"Indivior Pharmaceuticals Enters $175 Million Accelerated Share Repurchase Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2632930082","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632930082?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:42","pubTimestamp":1777894963,"startTime":"0","endTime":"0","summary":"Indivior Pharmaceuticals  has entered into a $175 million accelerated share repurchase agreement with Barclays Bank, to be executed under the company's existing $400 million buyback program, Indivior said Monday.The company will make a $175 million upfront payment to Barclays and expects to receive an initial delivery of 3,717,473 shares following execution.Indivior said it expects final settlement no later than the end of June.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632303619","title":"Indivior announces $175M accelerated share repurchase program","url":"https://stock-news.laohu8.com/highlight/detail?id=2632303619","media":"TIPRANKS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632303619?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:17","pubTimestamp":1777893452,"startTime":"0","endTime":"0","summary":"Indivior (INDV) announced that it has entered into a $175M accelerated share repurchase agreement with Barclays. The ASR will be executed under Ind...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/indivior-announces-175m-accelerated-share-repurchase-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/indivior-announces-175m-accelerated-share-repurchase-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632793756","title":"Indivior Announces $175 Million Accelerated Share Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2632793756","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632793756?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:00","pubTimestamp":1777892402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nTUA35HS5Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632626194","title":"Indivior Earnings Call Highlights SUBLOCADE-Fueled Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2632626194","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632626194?lang=en_us&edition=fundamental","pubTime":"2026-05-02 08:09","pubTimestamp":1777680579,"startTime":"0","endTime":"0","summary":"Indivior plc (($INDV)) has held its Q1 earnings call. Read on for the main highlights of the call. Indivior’s latest earnings call struck an upbeat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/indivior-earnings-call-highlights-sublocade-fueled-momentum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/indivior-earnings-call-highlights-sublocade-fueled-momentum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631589856","title":"Indivior Pharmaceuticals, Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2631589856","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631589856?lang=en_us&edition=fundamental","pubTime":"2026-04-30 21:22","pubTimestamp":1777555335,"startTime":"0","endTime":"0","summary":"Indivior Pharmaceuticals, Inc reports results for the quarter ended March 31 - Earnings SummaryIndivior Pharmaceuticals, Inc INDV.OQ reported quarterly adjusted earnings of 96 cents per share for the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nL8N41D29Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631365166","title":"Indivior Pharmaceuticals Q1 revenue rises 19%, beats estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2631365166","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631365166?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:12","pubTimestamp":1777547562,"startTime":"0","endTime":"0","summary":"Indivior Pharmaceuticals Q1 revenue rises 19%, beats estimatesOverviewU.S. opioid treatment maker's Q1 revenue rose 19% yr/yr, beating analyst expectationsRecord adjusted EBITDA for Q1 more than doubl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nL1N41D0OJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631636546","title":"Indivior Pharmaceuticals Q1 Revenue USD 317 Million Vs. IBES Estimate USD 272.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631636546","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631636546?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:12","pubTimestamp":1777547560,"startTime":"0","endTime":"0","summary":"Apr 30 (Reuters) - Indivior Pharmaceuticals Q1 net income USD 89 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 30-APR-202610:59:11.847 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nRSD388hYw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631636892","title":"Indivior Q1 GAAP net income rises 89% to $89 million; revenue climbs 19% to $317 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631636892","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631636892?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:08","pubTimestamp":1777547338,"startTime":"0","endTime":"0","summary":"Indivior posted Q1 2026 GAAP net income of $89 million, compared with $123 million in non-GAAP net income.Adjusted EBITDA more than doubled to $164 million.SUBLOCADE net revenue climbed 32% to $232 million, driven by 20% dispense unit volume growth.Full-year 2026 guidance was raised to revenue of $1.22 billion-$1.29 billion and adjusted EBITDA of $620 million-$660 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indivior Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL4XpQWM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631463561","title":"Indivior Q1 Adj. EPS $0.96 Beats $0.66 Estimate, Sales $317.000M Beat $272.840M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2631463561","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631463561?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:02","pubTimestamp":1777546946,"startTime":"0","endTime":"0","summary":"Indivior (NASDAQ:INDV) reported quarterly earnings of $0.96 per share which beat the analyst consensus estimate of $0.66 by 45.45 percent. This is a 134.15 percent increase over earnings of $0.41 per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/04/52164174/indivior-q1-adj-eps-0-96-beats-0-66-estimate-sales-317-000m-beat-272-840m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631635789","title":"Indivior Pharmaceuticals, Inc - Revises FY 2026 Net Revenue Guidance to $1,215 Mln-$1,285 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2631635789","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631635789?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:00","pubTimestamp":1777546805,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nPLX771921:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631635732","title":"Indivior Pharmaceuticals, Inc - Revises FY 2026 Adj Ebitda Guidance to $620 Mln-$660 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2631635732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631635732?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:00","pubTimestamp":1777546805,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nPLX771921:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631352756","title":"Indivior Pharmaceuticals, Inc - Revises FY 2026 Sublocade Net Revenue Guidance to $950 Mln-$990 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2631352756","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631352756?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:00","pubTimestamp":1777546805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nPLX771921:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631064045","title":"Addex Therapeutics publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631064045","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631064045?lang=en_us&edition=fundamental","pubTime":"2026-04-30 13:28","pubTimestamp":1777526912,"startTime":"0","endTime":"0","summary":"Addex Therapeutics published its annual report for 2025, highlighting progress in chronic cough and brain injury recovery programs.Indivior completed IND-enabling studies for selected GABAB PAM candidate in substance use disorder under existing partnership.Addex reported its independently selected GABAB PAM candidate showed robust anti-tussive effects across several preclinical models for chronic cough.Company signed option and collaboration agreement with Sinntaxis on April 30, 2025 to secure exclusive IP license covering use of mGlu5 inhibitors in brain injury recovery.Addex regained full development and commercialization rights to Phase 2 mGlu2 PAM asset ADX71149 from Johnson and Johnson.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL6TntrR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1496350502.SGD","JNJ","LU2756315318.SGD","IE00B1BXHZ80.USD","LU1894683264.USD","LU1074936037.SGD","LU2756315664.SGD","LU1059921491.USD","IE00BN8TJ469.HKD","LU1551013342.USD","LU0058720904.USD","IE00B19Z3581.USD","LU1244550494.USD","INDV","LU1280957306.USD","LU0203347892.USD","LU0320765646.SGD","IE00BDGV0183.EUR","LU0426412945.USD","LU1221951046.USD","LU2471134952.CNY","LU1121112475.USD","IE00B4R5TH58.HKD","IE000MB6IJN5.SGD","LU1935042991.SGD","LU1043141123.HKD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU1674673691.USD","IE00B3PB1722.GBP","LU0234570918.USD","SG9999002224.SGD","SG9999001176.USD","LU0795875086.SGD","LU2592432038.USD","LU2471134796.USD","BK4588","IE0001KFT4U8.USD","LU0683600562.USD","LU0345769631.USD","LU1066051225.USD","LU1506573853.SGD","LU1267930813.SGD","LU1914381329.SGD","BK4581","LU2213496289.HKD","LU2487616109.SGD","IE00B3T34201.USD","LU0820561818.USD","IE00BVYPNV92.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631450524","title":"Addex FY25 net loss widens to CHF 6.7 million; cash falls to CHF 1.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631450524","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631450524?lang=en_us&edition=fundamental","pubTime":"2026-04-30 13:02","pubTimestamp":1777525339,"startTime":"0","endTime":"0","summary":"Addex posted a net loss of CHF 6.73 million in 2025, swinging from a prior-year profit as discontinued-operations profit fell to CHF 114,000.Revenue declined 57.8% to CHF 173,000 due to completion of the research phase of its Indivior collaboration on June 30, 2024.Operating loss widened to CHF 2.82 million as G&A held at CHF 2.32 million despite R&D easing to CHF 672,000.Cash slipped to CHF 1.64 million at year-end from a CHF 1.7 million net cash decrease during the year, while shareholders’ equity fell to CHF 4.77 million.Operationally, Addex advanced its GABAB PAM chronic cough candidate toward the clinic and continued repositioning dipraglurant for brain injury recovery, with CEO Tim Dyer citing “robust and sustained progress” and no financial outlook provided.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL9VRBZX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BKPKM429.USD","LU2210149790.SGD","INDV","BK4007","LU2210150020.SGD","NDAQ","SG9999014013.SGD","BK4588","LU2095319765.USD","IE00B64PRP62.GBP","BK4112","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU0314104364.USD","SG9999014005.SGD","IE00BN0W2T93.GBP","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630032126","title":"Evaluating Indivior Pharmaceuticals (NasdaqGS:INDV) After New ASAM 2026 Data On Sublocade Effectiveness","url":"https://stock-news.laohu8.com/highlight/detail?id=2630032126","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630032126?lang=en_us&edition=fundamental","pubTime":"2026-04-28 13:06","pubTimestamp":1777352819,"startTime":"0","endTime":"0","summary":"Indivior Pharmaceuticals (INDV) drew fresh investor attention after presenting new real world data at the ASAM 2026 Annual Conference in San Diego on its monthly extended release buprenorphine treatment, SUBLOCADE, for opioid use disorder.\nSee our latest analysis for Indivior Pharmaceuticals.\nThose ASAM data arrive at a time when Indivior Pharmaceuticals’ share price has shown an 18.43% 1 month share price return but remains slightly weaker year to date, while a very large 1 year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior-pharmaceuticals/news/evaluating-indivior-pharmaceuticals-nasdaqgsindv-after-new-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior-pharmaceuticals/news/evaluating-indivior-pharmaceuticals-nasdaqgsindv-after-new-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["INDV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629828725","title":"Indivior study links Sublocade-based OUD remission to better quality-of-life outcomes","url":"https://stock-news.laohu8.com/highlight/detail?id=2629828725","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629828725?lang=en_us&edition=fundamental","pubTime":"2026-04-24 23:01","pubTimestamp":1777042916,"startTime":"0","endTime":"0","summary":"Indivior presented new real-world findings at ASAM 2026 on April 24, 2026, highlighting clinical benefits of monthly injectable buprenorphine  in opioid use disorder.Ontario health-data analysis of more than 45,000 patients linked higher time on medication treatment to fewer overdose events versus time off treatment.Study also indicated buprenorphine-based options, including SUBLOCADE, were associated with lower overdose risk versus no medication treatment.Separate ROUTE study provisional results in 443 participants tied remission on SUBLOCADE to improved patient-relevant outcomes such as reduced craving and better quality of life.Readout supported remission as a treatment endpoint beyond abstinence, reinforcing Indivior strategy around long-acting injectable buprenorphine.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDLc2Q2vl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2095319765.USD","LU2210149790.SGD","INDV","IE00BKPKM429.USD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU0314104364.USD","SG9999014039.USD","BK4588","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","SG9999014005.SGD","NDAQ","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4007","SG9999014021.USD","BK4112","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628875051","title":"Does Indivior (INDV) Survey Support For Long-Acting Buprenorphine Strengthen Its Criminal Justice Strategy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2628875051","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628875051?lang=en_us&edition=fundamental","pubTime":"2026-04-19 09:09","pubTimestamp":1776560990,"startTime":"0","endTime":"0","summary":"In April 2026, Indivior PLC reported results from a national survey showing that correctional leaders see staffing and coordination gaps as major barriers to preventing diversion of medications for opioid use disorder, and view long-acting injectable buprenorphine as a practical way to improve treatment in jails and prisons.\nThe survey’s strong support among correctional professionals for long-acting injectable buprenorphine highlights a potential opportunity for wider use of Indivior’s...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior-pharmaceuticals/news/does-indivior-indv-survey-support-for-long-acting-buprenorph","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-indv/indivior-pharmaceuticals/news/does-indivior-indv-survey-support-for-long-acting-buprenorph","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":120,"code":"91000000","status":"200"}]}}